Tags

Type your tag names separated by a space and hit enter

[Transjugular intrahepatic portasystemic stent shunt (TIPSS). Indications and postoperative management].
Radiologe. 1994 Apr; 34(4):164-7.R

Abstract

Complications of portal hypertension, e.g. bleeding from esophageal or gastric varices or ascites, can be efficiently treated by transjugular intrahepatic portosystemic stent shunting. The most important and most frequently encountered contra-indications to this procedure are malignant liver tumors, systemic infections or hepatic decompensation, and encephalopathy. Before and after the shunt procedure, treatment of these patients must be selected and administered with due consideration for the fact that they extremely prone to bacterial infections and have many concomitant diseases, e.g. impaired renal function. To prevent early occlusion of the stent, patients receive anticoagulants in the first few days after the procedure.

Authors+Show Affiliations

Theilmann L
Medizinische Universitätsklinik Heidelberg.
Sauer P
No affiliation info available

MeSH

Esophageal and Gastric VaricesGastrointestinal HemorrhageHumansHypertension, PortalLiver Function TestsPortasystemic Shunt, SurgicalPostoperative CarePostoperative ComplicationsStents

Pub Type(s)

English Abstract
Journal Article
Review

Language

ger

PubMed ID

8052706

Citation

Theilmann, L, and P Sauer. "[Transjugular Intrahepatic Portasystemic Stent Shunt (TIPSS). Indications and Postoperative Management]." Der Radiologe, vol. 34, no. 4, 1994, pp. 164-7.
Theilmann L, Sauer P. [Transjugular intrahepatic portasystemic stent shunt (TIPSS). Indications and postoperative management]. Radiologe. 1994;34(4):164-7.
Theilmann, L., & Sauer, P. (1994). [Transjugular intrahepatic portasystemic stent shunt (TIPSS). Indications and postoperative management]. Der Radiologe, 34(4), 164-7.
Theilmann L, Sauer P. [Transjugular Intrahepatic Portasystemic Stent Shunt (TIPSS). Indications and Postoperative Management]. Radiologe. 1994;34(4):164-7. PubMed PMID: 8052706.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Transjugular intrahepatic portasystemic stent shunt (TIPSS). Indications and postoperative management]. AU - Theilmann,L, AU - Sauer,P, PY - 1994/4/1/pubmed PY - 1994/4/1/medline PY - 1994/4/1/entrez SP - 164 EP - 7 JF - Der Radiologe JO - Radiologe VL - 34 IS - 4 N2 - Complications of portal hypertension, e.g. bleeding from esophageal or gastric varices or ascites, can be efficiently treated by transjugular intrahepatic portosystemic stent shunting. The most important and most frequently encountered contra-indications to this procedure are malignant liver tumors, systemic infections or hepatic decompensation, and encephalopathy. Before and after the shunt procedure, treatment of these patients must be selected and administered with due consideration for the fact that they extremely prone to bacterial infections and have many concomitant diseases, e.g. impaired renal function. To prevent early occlusion of the stent, patients receive anticoagulants in the first few days after the procedure. SN - 0033-832X UR - https://www.unboundmedicine.com/medline/citation/8052706/[Transjugular_intrahepatic_portasystemic_stent_shunt__TIPSS___Indications_and_postoperative_management]_ L2 - https://medlineplus.gov/gastrointestinalbleeding.html DB - PRIME DP - Unbound Medicine ER -